Patents by Inventor Hans Mark

Hans Mark has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VASOPROTECTIVE AND CARDIOPROTECTIVE ANTIDIABETIC THERAPY
    Publication number: 20240156823
    Abstract: The present invention relates to certain DPP-4 inhibitors for treating and/or preventing oxidative stress, vascular stress and/or endothelial dysfunction as well as to the use of such DPP-4 inhibitors in treatment and/or prevention of diabetic or non-diabetic patients, including patient groups at risk of cardiovascular and/or renal disease.
    Type: Application
    Filed: January 10, 2024
    Publication date: May 16, 2024
    Inventors: Thomas KLEIN, Andreas DAIBER, Odd-Erik JOHANSEN, Michael MARK, Sanjaykumar PATEL, Hans-Juergen WOERLE
  • TREATMENT FOR DIABETES IN PATIENTS WITH INSUFFICIENT GLYCEMIC CONTROL DESPITE THERAPY WITH AN ORAL ANTIDIABETIC DRUG
    Publication number: 20240148737
    Abstract: The present invention relates to the finding that certain DPP-4 inhibitors are particularly suitable for treating and/or preventing metabolic diseases, particularly diabetes, in patients with insufficient glycemic control despite a therapy with an oral and/or a non-oral antidiabetic drug.
    Type: Application
    Filed: January 16, 2024
    Publication date: May 9, 2024
    Inventors: Eva Ulrike GRAEFE-MODY, Thomas KLEIN, Michael MARK, Hans-Juergen WOERLE
  • Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug
    Patent number: 11911388
    Abstract: The present invention relates to the finding that certain DPP-4 inhibitors are particularly suitable for treating and/or preventing metabolic diseases, particularly diabetes, in patients with insufficient glycemic control despite a therapy with an oral and/or a non-oral antidiabetic drug.
    Type: Grant
    Filed: February 11, 2021
    Date of Patent: February 27, 2024
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Eva Ulrike Graefe-Mody, Thomas Klein, Michael Mark, Hans-Juergen Woerle
  • Vasoprotective and cardioprotective antidiabetic therapy
    Patent number: 11911387
    Abstract: The present invention relates to certain DPP-4 inhibitors for treating and/or preventing oxidative stress, vascular stress and/or endothelial dysfunction as well as to the use of such DPP-4 inhibitors in treatment and/or prevention of diabetic or non-diabetic patients, including patient groups at risk of cardiovascular and/or renal disease.
    Type: Grant
    Filed: December 15, 2020
    Date of Patent: February 27, 2024
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Thomas Klein, Andreas Daiber, Odd-Erik Johansen, Michael Mark, Sanjaykumar Patel, Hans-Juergen Woerle
  • METHOD OF MANUFACTURING AN INSULATED, IMPACT RESISTANT WINDOW
    Publication number: 20090311449
    Abstract: An insulated glass unit (IGU) is provided. The IGU meets the industry standards for impact resistance while significantly reducing the weight of the IGU compared to conventional IGUs. In particular, the two pane IGUs of the present invention can meet or exceed industry standards for various wind storm criteria while reducing the weight and cost of the IGU. The IGU only requires one layer of film to meet the performance of previous IOU designs that require two or more layers of film laminated to two or more surfaces of glass.
    Type: Application
    Filed: June 10, 2009
    Publication date: December 17, 2009
    Inventors: Hans Mark Fehlmann, Jeffrey Pratt, John Storms, Michael W. Sullivan, David W. Avison, Karen Hayden, Frank A. Mannarino
  • Adaptable user interface for business software
    Publication number: 20060200771
    Abstract: An adaptable user interface is formed based on a role assumed by a user and the identification of tasks in a process that need to be performed. For each role assumed by the user, a set of tasks assigned to the role is identified. Each task is evaluated to determine if it is an active task that needs to be performed in one or more processes. For each active task, an element is added to the user interface.
    Type: Application
    Filed: September 23, 2005
    Publication date: September 7, 2006
    Applicant: Microsoft Corporation
    Inventors: Jakob Nielsen, Nicholas Lowe, Kevin Honeyman, Cary Rohwer, Brian Glaeske, Hans Mark, Morten Holm-Petersen, Arne de Booij